This document is an attestation letter from Neuspera Medical Inc. to the Federal Communications Commission (FCC). The letter addresses compliance with FCC regulations, specifically CFR 47 §2.911(d)(5)(ii) filing requirements. It serves as a formal declaration regarding the company's status in relation to the Covered List.
The letter confirms that, as of the date of filing the application, Neuspera Medical Inc. is not identified on the Covered List as an entity producing "covered" equipment. This attestation is crucial for demonstrating adherence to FCC guidelines and ensuring the eligibility of Neuspera's products for certification and market access within the United States.
The document includes the FCC ID (2BMNE-WT-002) for reference and is signed by Dr. Alexander Yeh, CTO, VP R&D of Neuspera Medical Inc. The letter also provides contact information and the company's address for official correspondence.
Array
(
[0] => Array
(
[url_sha] => 7d8bfc7f0566707e1056fb6eea6db2cecad26e070b3830c6179cd825294781cb
[source] => fccid
[url] => https://apps.fcc.gov/eas/GetApplicationAttachment.html?id=8308087
[href_text] => 2.911 (d)(5)(ii) Attestation Statement
[href_description] => Neuspera Medical Inc. WT-002 Neurostimulator Powering Device 2BMNE-WT-002 2BMNEWT002 wt 002
[http_status] => 200
[http_lastmod] => 0000-00-00 00:00:00
[http_contenttype] =>
[http_filename] => GetApplicationAttachment.html?id=8308087
[http_size] => 329155
[file_sha256] => 86785fca684807e269f622a20483deacba463b3712df9bdbe20e4feb63c869ac
[domain] => document.fccid
)
)
Array
(
[file_sha256] => 86785fca684807e269f622a20483deacba463b3712df9bdbe20e4feb63c869ac
[cleanFccId] => 2BMNEWT002
[title] => Neuspera Medical Inc. Attestation Letter for FCC Compliance
[description] => Attestation letter from Neuspera Medical Inc. confirming compliance with FCC regulations and attesting to covered list status.
[brand_name] => Neuspera
[keywords] => ["2BMNE-WT-002", "WT-002", "FCC", "Attestation", "2.911(d)(5)(ii)"]
[intro] =>
This document is an attestation letter from Neuspera Medical Inc. to the Federal Communications Commission (FCC). The letter addresses compliance with FCC regulations, specifically CFR 47 §2.911(d)(5)(ii) filing requirements. It serves as a formal declaration regarding the company's status in relation to the Covered List.
The letter confirms that, as of the date of filing the application, Neuspera Medical Inc. is not identified on the Covered List as an entity producing "covered" equipment. This attestation is crucial for demonstrating adherence to FCC guidelines and ensuring the eligibility of Neuspera's products for certification and market access within the United States.
The document includes the FCC ID (2BMNE-WT-002) for reference and is signed by Dr. Alexander Yeh, CTO, VP R&D of Neuspera Medical Inc. The letter also provides contact information and the company's address for official correspondence.
)
Array
(
[0] => Array
(
[id] => 8308087
[file_sha256] =>
[applicationId] => r4BN3DPg6fQa6D9VGAMKkg==
[description] => 2.911 (d)(5)(ii) Attestation Statement
[shortTermConfidential] => No
[permanentConfidential] => No
[supercede] => No
[exhibitType] => Attestation Statements
[fileType] => Adobe Acrobat PDF
[displayType] => pdf
[fileSize] => 329155
[submissionDate] => 2025-05-20 00:00:00
[dateAvailable] => 2025-05-20 00:00:00
[creationDate] =>
[producer] =>
[modDate] =>
[title] =>
[creator] =>
[author] =>
[pages] =>
[realSize] =>
[html] => 0
[png] => 0
[txt] => 0
[version] => 1
[source] => 0
[fccId] => 2BMNE-WT-002
[cleanFccId] => 2BMNEWT002
[exif] => 0
)
)